*ThisisthelifetimeASCVDriskforanindividualatage50yearswithyourriskfactorlevels.Inrarecases,10-yearrisksmayexceedlifetimerisksgiventhattheestimatescomefromdifferentapproaches.While10-yearriskestimatesarederivedfrommethodsanddatausingcontinuousvariables,thereportedestimateoflifetimeriskisbasedonassigningeachpersonintoone...
此外,其他的方法还有欧洲心血管危险评估(SCORE)系统,英国的新型心血管风险评分QRISK、QRISK2模型等。 ASCVD的“危险分层”及降脂目标值 影响ASCVD整体风险评估的主要因素包括:高血压、胆固醇升高、糖尿病、缺乏运动、年龄(男≥45岁、女≥55岁)、吸烟、HDL-C低...
ASCVD Risk Stratification. Atherosclerotic cardiovascular disease (ASCVD) is a major cause of morbidity and mortality worldwide. The American College of Cardiology (ACC) and American Heart Association (AHA) have developed a risk stratification system to identify individuals at high risk of developing AS...
1、RiskFactor Sex Age Race TotalCholesterol HDL-Cholesterol SystolicBloodPressure TreatmentforHighBloodPressure Diabetes Smoker Your10-YearASCVDRisk(%) 10-Year ASCVD Risk (%) for Someone Your Age with Optimal Risk Factor Levels (shown above in column E) YourLifetimeASCVDRisk*(%) Lifetime ASCVD ...
美国哈佛大学布莱根妇女医院的青年学者Samia Mora以及Olga Demler团队汇报了研究项目:DEVELOPMENT AND VALIDATION OF A NOVEL 10-YEAR RESIDUAL RISK SCORE (RRS) IN THE UK BIOBANK AND MASSACHUSETTS GENERAL BRIGHAM POPULATIONS FOR PATIENTS ...
1、Risk FactorSexAgeRaceTotal CholesterolHDL-CholesterolSystolic Blood PressureTreatme nt for High Blood PressureDiabetesSmokerYour 10-Year ASCVD Risk (%)10-Year ASCVD Risk (%) for Some one Your Age with Optimal Risk Factor Levels (shown above in column E)Your Lifetime ASCVD Risk* (%)Lifetime...
[12] Mason RP. A rationale for combination therapy in risk factor management: a mechanistic perspective. Am J Med. 2005 Dec;118 Suppl 12A:54-61. [13] Fogari R, et al. Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese ...
*ThisisthelifetimeASCVDriskforanindividualatage50yearswithyourriskfactorlevels.Inrarecases,10-yearrisksmayexceedlifetimerisksgiventhattheestimatescomefromdifferentapproaches.While10-yearriskestimatesarederivedfrommethodsanddatausingcontinuousvariables,thereportedestimateoflifetimeriskisbasedonassigningeachpersonintoone...
ten-year risk of ascvd计算十年ASCVD风险评估是根据患者的年龄、性别、总胆固醇水平、高密度脂蛋白胆固醇水平、血压以及是否患有糖尿病等因素来计算的。具体评估流程如下: 1.确定患者的年龄和性别。 2.检查患者的总胆固醇水平、高密度脂蛋白胆固醇水平以及血压是否正常。 3.检查患者是否患有糖尿病。 4.根据以上信息,...
[5] Aguiar C, Alegria E, Bonadonna RC, et al. A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy.Atheroscler Suppl. 2015;19:1-12. ...